Development of a pre-clinical mouse model of Estrogen receptor alpha positive breast cancer to investigate the clinical efficacy of Selective Estrogen Receptor Modulators (SERMs)
Development of a pre-clinical mouse model of Estrogen receptor alpha positive breast cancer to investigate the clinical efficacy of Selective Estrogen Receptor Modulators (SERMs)
批准号:
341905
负责人:
Muller William J
金额:
$59.59万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-03-01 至 2022-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Breast cancer remains a prevalent disease and major cause of morbidity in women. Amongst the most prevalent oncogene drivers in breast cancer is the Estrogen Receptor alpha (ERa), one of the major receptors for estrogens. Treatment of ERa positive breast
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
-
批准号:488246
-
项目类别:Operating Grants
-
资助金额:$83.04万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Chi3L1 (YKL-40) plays a multifaceted role in modulating tumor immune microenvironment during breast cancer progression.
-
批准号:478513
-
项目类别:Operating Grants
-
资助金额:$93.07万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
-
批准号:483129
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Identification of Stat1 signaling pathway(s) involved in mediating tumor escape from immune surveillance.
-
批准号:490747
-
项目类别:Operating Grants
-
资助金额:$4.55万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
The multifaceted role of c-Src tyrosine kinase in breast cancer progression.
-
批准号:468470
-
项目类别:Operating Grants
-
资助金额:$83.6万
-
财政年份:2022
-
负责人:Muller William J
-
依托单位:
Chi3L1 (YKL-40) plays a multifaceted role in modulating tumor immune microenvironment during breast cancer progression.
-
批准号:472379
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Muller William J
-
依托单位:
Role of epigenetic modulation in breast cancer etiology and drug resistance.
-
批准号:368101
-
项目类别:Operating Grants
-
资助金额:$43.71万
-
财政年份:2017
-
负责人:Muller William J
-
依托单位:
The role of an alternative ErbB2 splice isoform in lung and breast cancer progression.
-
批准号:341907
-
项目类别:Operating Grants
-
资助金额:$59.59万
-
财政年份:2016
-
负责人:Muller William J
-
依托单位:
Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer
-
批准号:333085
-
项目类别:Operating Grants
-
资助金额:$274.58万
-
财政年份:2015
-
负责人:Muller William J
-
依托单位:
Canada Research Chair Tier 1
-
批准号:341360
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2015
-
负责人:Muller William J
-
依托单位:
Oncogene-mediated signal transduction in ErbB2 transgenic models of mammary tumour progression
-
批准号:280158
-
项目类别:Operating Grants
-
资助金额:$56.09万
-
财政年份:2013
-
负责人:Muller William J
-
依托单位:
Identification of PI-3K coupled signalling pathways involved in mammary tumour progression: Implication for resistance to targeted therapy.
-
批准号:291796
-
项目类别:Operating Grants
-
资助金额:$61.28万
-
财政年份:2013
-
负责人:Muller William J
-
依托单位:
Role of epigenetic modulation in breast cancer etiology and drug resistance
-
批准号:277365
-
项目类别:Operating Grants
-
资助金额:$54.64万
-
财政年份:2012
-
负责人:Muller William J
-
依托单位:
Integrin-mediated signal transduction in mammary tumourigenesis and metastasis
-
批准号:249551
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2011
-
负责人:Muller William J
-
依托单位:
The role of ErbB2-14-3-3 sigma signaling axis in cancer and development
-
批准号:199253
-
项目类别:Operating Grants
-
资助金额:$56.71万
-
财政年份:2010
-
负责人:Muller William J
-
依托单位:
The role of Epidermal Growth Factor Receptor Family in mammary tumorigenesis and metastasis
-
批准号:171470
-
项目类别:Operating Grants
-
资助金额:$56.48万
-
财政年份:2008
-
负责人:Muller William J
-
依托单位:
海外基金